AGP Executive Report
Last update: 24 minutes agoMeningococcal Alert (WA): WA Health has issued another warning after a child was rushed to hospital with meningococcal disease, with serogroup B cases again in focus. Authorities note the illness is rare but life-threatening, and vaccines are available and free for eligible children and teens. Meningococcal Alert (Second Case): A second WA child has been hospitalised with serogroup B within weeks, prompting renewed calls for families to ensure they’re up to date with MenACWY and related immunisations. Paramedic Prescribing (Health Policy): Health Minister Simeon Brown says paramedics will be able to prescribe from a list of 232 medicines, covering common infections, repeat prescriptions for long-term conditions, and urgent community care—aiming to reduce delays and unnecessary after-hours visits. Cancer Treatment Update (Europe): The EU’s CHMP has issued a positive opinion for relacorilant (Lifyorli) combined with nab-paclitaxel for platinum-resistant ovarian cancer, moving the therapy closer to potential European approval. Plastic Additive & Neurodevelopment (Research): Australian researchers report a potential link between the plastic softener DEHP and autism/ADHD, using cord testing and DNA “gene-switching” analysis to explore how exposure may affect risk before birth. Digital Safety for Kids (EU): The European Commission proposes an “EU Kids Act” including a ban on social media for under-13s and stricter rules for child accounts and addictive design features.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.